Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.43 |
| ▸ | ACLY | P53396 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 5/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17500181 | 1.00 | TSHR (0.48) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL9391580 | 1.00 | TSHR (0.48) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL12204769 | 1.00 | TSHR (0.48) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL27509626 | 0.90 | — | — | |
| SCHEMBL16600537 | 0.83 | TSHR (0.44) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL7704790 | 0.82 | ALDH1A1 (0.38) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL11590002 | 0.80 | TSHR (0.43) | TSHRFAAHTRPV1ACLYHIF1A | |
| SCHEMBL17822144 | 0.80 | TSHR (0.48) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL16491137 | 0.80 | TSHR (0.52) | TSHRFAAHTRPV1ACLYALDH1A1 | |
| SCHEMBL537433 | 0.80 | TSHR (0.52) | TSHRFAAHTRPV1ACLYALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170247314-A1 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | P2 SCIENCE, INC. | 2017-08-31 | — | — | US | disclosed |
| WO-2017139637-A1 | FRAGRANCE COMPOSITIONS COMPRISING COMPOUNDS WITH OLFACTORY QUALITIES | P2 SCIENCE, INC. (US) | 2017-08-17 | — | — | WO | disclosed |
| WO-2016022803-A2 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | P2 SCIENCE, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170247314-A1 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | ELOVL5, FASN, ELOVL1 | TSHR 4078/4885FAAH 7/4885TRPV1 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.